NIKA PHARMACEUTICALS INC. (NIKA)
OTC Markets OTCQB · USD · Healthcare · Drug Manufacturers - Specialty & Generic
$0.35 (+0.00%) as of
Key statistics
- Market cap
- 366.99M
- EPS (TTM)
- 0.0000
- Dividend yield
- 0.00%
- 52-week range
- 0.2000 – 0.9750
- Beta
- -1.71
- Profit margin
- 0.00%
- Volume
- 22.00
About NIKA PHARMACEUTICALS INC.
Nika Pharmaceuticals, Inc. engages in the development and distribution pharmaceutical products for dietary supplements and antiviral drugs in the United States. The company offers ITV-1, TNG, physiolong, carotilen, fructin, dry boza, anthocylen C, hypocholestin, biodetoxin, silymaron, and solamentum products. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Henderson, NV, United States
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.